Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Viracta Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −7 vs. Q1 2023
- Shares held
- 9.97M
- −2.25M (−18.4%) vs. Q1 2023
- Total value
- $14.1M
- −$5.37M (−27.7%) vs. Q1 2023
- New holders
- 4
- 7 more added
- Sold out
- 11
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $3.80K |
| Q4 2024 | 32 | $583.0K |
| Q3 2024 | 38 | $1.29M |
| Q2 2024 | 40 | $4.91M |
| Q1 2024 | 40 | $9.58M |
| Q4 2023 | 42 | $5.56M |
| Q3 2023 | 42 | $10.1M |
| Q2 2023 | 41 | $14.1M |
| Q1 2023 | 48 | $19.4M |
| Q4 2022 | 56 | $18.1M |
| Q3 2022 | 59 | $52.8M |
| Q2 2022 | 63 | $44.2M |
| Q1 2022 | 69 | $62.2M |
| Q4 2021 | 69 | $51.8M |
| Q3 2021 | 68 | $124.6M |
| Q2 2021 | 63 | $151.8M |
| Q1 2021 | 50 | $92.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 3,614,662 | $5.10M | 0.14% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,520,343 | $2.14M | 0.00% | −36,980−2.4% | Reduced |
| Vanguard Group Inc | 1,147,912 | $1.62M | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 698,000 | $984.2K | 0.04% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 689,709 | $972.5K | 0.17% | 00.0% | Unchanged |
| BlackRock Inc. | 460,235 | $648.9K | 0.00% | +12,434+2.8% | Added |
| MAI Capital Management | 307,570 | $433.7K | 0.01% | −71,898−18.9% | Reduced |
| Aisling Capital Management LP | 288,571 | $406.9K | 0.20% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 224,438 | $316.5K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 167,818 | $235.0K | 0.00% | +71,683+74.6% | Added |
| Renaissance Technologies LLC | 134,799 | $190.0K | 0.00% | +9,500+7.6% | Added |
| Bridgeway Capital Management, LLC | 125,000 | $176.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 65,867 | $92.9K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 63,406 | $89.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 58,850 | $83.0K | 0.00% | +2,964+5.3% | Added |
| Millennium Management LLC | 54,595 | $77.0K | 0.00% | −90,752−62.4% | Reduced |
| Dimensional Fund Advisors LP | 52,888 | $74.6K | 0.00% | −71,543−57.5% | Reduced |
| Bailard, Inc. | 47,700 | $67.3K | 0.00% | +27,800+139.7% | Added |
| Jane Street Group, LLC | 41,854 | $59.0K | 0.00% | −13,611−24.5% | Reduced |
| Northern Trust Corp | 38,511 | $54.3K | 0.00% | −198−0.5% | Reduced |
| Trust Co of Toledo NA | 35,006 | $49.4K | 0.01% | +7,006+25.0% | Added |
| Bank of America Corp | 18,038 | $25.4K | 0.00% | −5,203−22.4% | Reduced |
| HRT Financial LP | 17,291 | $24.0K | 0.00% | +17,291 | New |
| Susquehanna International Group, LLP | 16,793 | $23.7K | 0.00% | +16,793 | New |
| Hoylecohen, LLC | 14,000 | $19.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 12,719 | $17.9K | 0.00% | −3,000−19.1% | Reduced |
| Charles Schwab Investment Management Inc | 12,430 | $17.5K | 0.00% | 00.0% | Unchanged |
| United Bank | 10,205 | $14.4K | 0.00% | 00.0% | Unchanged |
| Bourgeon Capital Management LLC | 7,500 | $10.6K | 0.00% | −1,500−16.7% | Reduced |
| Tower Research Capital LLC (TRC) | 5,042 | $7.11K | 0.00% | −10,557−67.7% | Reduced |
| Advisor Group Holdings, Inc. | 4,564 | $6.12K | 0.00% | 00.0% | Unchanged |
| RP Management, LLC | 3,700 | $5.22K | 0.01% | 00.0% | Unchanged |
| IAG Wealth Partners, LLC | 3,000 | $4.23K | 0.00% | +3,000 | New |
| Barclays PLC | 2,668 | $3.76K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 721 | $1.02K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 343 | $484 | 0.00% | +8+2.4% | Added |
| Group One Trading, L.P. | 100 | $141 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 8 | $12 | 0.00% | +8 | New |
| Parallel Advisors, LLC | 8 | $11 | 0.00% | 00.0% | Unchanged |
| Addison Advisors LLC | 4 | $6 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 296 | $0 | 0.00% | −2,711−90.2% | Reduced |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −1,487,385−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −160,515−100.0% | Sold out |
| Jasper Ridge Partners, L.P. | 0 | $0 | 0.00% | −92,939−100.0% | Sold out |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −35,791−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,549−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,681−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −7,928−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −238−100.0% | Sold out |